Business Context and Reporting Period
Company: CytoSorbents Corporation (Nasdaq: CTSO)
Filing Type: Form 8-K (Current Report)
Date of Report: August 6, 2019
Reporting Period: This filing announces financial results for the quarter and six months ended June 30, 2019. The specific financial data is contained in the press release furnished as Exhibit 99.1, which is not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1) but are not present in the body of this 8-K document.
Material Changes
No material changes or comparative financial data versus prior periods are disclosed within the text of this filing. The document serves solely as a notification that results for the period ended June 30, 2019, have been issued.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release by the company on August 6, 2019, regarding its financial results.
Legal Disclaimer: The information in Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Guidance/Risks: No specific guidance, outlook, risks, or contingencies are detailed in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 6, 2019) for actual revenue, net loss, and cash position figures.
- Verify the specific operational highlights and segment performance mentioned in the press release.
- Check for any updated forward-looking statements or guidance provided in the press release.
- Confirm the company's liquidity status and cash burn rate as detailed in the full financial report.